Filing Flows › Comparisons › XLO vs DERM
Xilio Therapeutics vs Journey Medical: XLO and DERM compared
Xilio Therapeutics is the larger company: $18.7M of revenue in its latest quarter (Q2 2026) against $18.5M for Journey Medical (Q2 2026). Xilio Therapeutics is growing faster (+131% against +23% a year earlier). Journey Medical is more profitable, with an operating margin of 2.5% against -18.7%.
Where the money goes: XLO and DERM
Xilio Therapeutics (XLO) · Q2 2026
Xilio Therapeutics, Q2 2026: revenue $18.7M (+131% year over year), operating margin -18.7%, net loss $6.4M, operating cash flow −$18.8M. The chart follows the revenue to costs, profit and cash.
Journey Medical (DERM) · Q2 2026
Journey Medical, Q2 2026: revenue $18.5M (+23% year over year), operating margin 2.5%, net loss $312K, operating cash flow −$1.7M. The chart follows the revenue to costs, profit and cash.
| Xilio Therapeutics (XLO) | Journey Medical (DERM) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $18.7M | $18.5M |
| Revenue growth, Y/Y | +131% | +23% |
| Operating margin | -18.7% | 2.5% |
| Net earnings | −$6.4M | −$312K |
| Net margin | -34.1% | -1.7% |
| Operating cash flow | −$18.8M | −$1.7M |
Where the revenue comes from
Journey Medical
- Emrosi: $8.1M (44%)
- Qbrexza: $5.1M (28%)
- Accutane: $3.4M (18%)
- Foam franchise products (Amzeeq & Zilxi): $941K (5%)
Questions
Which is bigger, Xilio Therapeutics or Journey Medical?
Xilio Therapeutics is the larger company: $18.7M of revenue in its latest quarter (Q2 2026) against $18.5M for Journey Medical (Q2 2026).
Is Xilio Therapeutics or Journey Medical growing faster?
Xilio Therapeutics is growing faster (+131% against +23% a year earlier).
Which is more profitable, Xilio Therapeutics or Journey Medical?
Journey Medical is more profitable, with an operating margin of 2.5% against -18.7%.
More: Xilio Therapeutics earnings · how Xilio Therapeutics makes money · Journey Medical earnings · how Journey Medical makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 12, 2026; 10-Q filed Aug 12, 2026). Fiscal quarters can end on different dates. Not investment advice.